Sensitivity to first-line chemotherapy for metastatic breast cancer in CHEK2 1100delC mutation carriers is not different compared with sporadic breast cancer patients

被引：0
|
作者：
Kriege, M. [1 ]
Jager, A. [1 ]
Hollestelle, A. [1 ]
Berns, P. M. J. J. [1 ]
Sieuwerts, A. M. [1 ]
Collee, J. M. [1 ]
Kroep, J. R. [2 ]
Martens, J. W. M. [1 ]
Hooning, M. J. [1 ]
Seynaeve, C. [1 ]
机构：
[1] Erasmus MC Canc Inst, Rotterdam, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [21] CHEK2:1100delC and female breast cancer in the United States
    Pereira, LHM
    Sigurdson, AJ
    Doody, MM
    Pineda, MA
    Alexander, BH
    Greene, MH
    Struewing, JP
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (03) : 541 - 543
  • [22] CHEK2 1100delC mutation in Russian ovarian cancer patients
    Nadezhda Yu Krylova
    Daria N Ponomariova
    Natalia Yu Sherina
    Natalia Yu Ogorodnikova
    Denis A Logvinov
    Natalia V Porhanova
    Oksana S Lobeiko
    Adel F Urmancheyeva
    Sergey Ya Maximov
    Alexandr V Togo
    Evgeny N Suspitsin
    Evgeny N Imyanitov
    Hereditary Cancer in Clinical Practice, 5
  • [23] CHEK2* 1100delC Mutation and Risk of Prostate Cancer
    Hale, Victoria
    Weischer, Maren
    Park, Jong Y.
    PROSTATE CANCER, 2014, 2014
  • [24] The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype
    Meijers-Heijboer, H
    Wijnen, J
    Vasen, H
    Wasielewski, M
    Wagner, A
    Hollestelle, A
    Elstrodt, F
    van den Bos, R
    de Snoo, A
    Fat, GTA
    Brekelmans, C
    Jagmohan, S
    Franken, P
    Verkuijlen, P
    van den Ouweland, A
    Chapman, P
    Tops, C
    Möslein, G
    Burn, J
    Lynch, H
    Klijn, J
    Fodde, R
    Schutte, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1308 - 1314
  • [25] Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America
    Iniesta, Maria D.
    Gorin, Michael A.
    Chien, Ling-Chen
    Thomas, Samantha M.
    Milliron, Kara J.
    Douglas, Julie A.
    Merajver, Sofia D.
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 136 - 140
  • [26] Frequency of the CHEK2 1100delC mutation among women with breast cancer:: An international study
    Zhang, Shiyu
    Phelan, Catherine M.
    Zhang, Phil
    Rousseau, Francois
    Ghadirian, Parviz
    Robidoux, Andre
    Foulkes, William
    Hamel, Nancy
    McCready, David
    Trudeau, Maureen
    Lynch, Henry
    Horsman, Douglas
    Leon De Matsuda, Maria Lourdes
    Aziz, Zeba
    Gomes, Magda
    Costa, Mauricio Magalhaes
    Liede, Alexander
    Poll, Aletta
    Sun, Ping
    Narod, Steven A.
    CANCER RESEARCH, 2008, 68 (07) : 2154 - 2157
  • [27] Frequency of the CHEK2 1100delC mutation in Korean women with early onset breast cancer
    Choi, Doo Ho
    Cho, Dae Yeon
    Lee, Pin Hyuk
    Park, Hee Sook
    Haffty, Bruce G.
    JOURNAL OF BREAST CANCER, 2008, 11 (01) : 25 - 29
  • [28] CHEK2 1100delC is not a risk factor for male breast cancer population
    Syrjäkoski, K
    Kuukasjärvi, T
    Auvinen, A
    Kallioniemi, OP
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (03) : 475 - 476
  • [29] CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Isinger, A
    Bhat, M
    Borg, A
    Nilbert, M
    BMC CANCER, 2006, 6 (1)
  • [30] Low frequency of CHEK2 1100delC mutation in breast cancer patients and hereditary breast cancer families in the Czech Republic.
    Kleibl, Z
    Novotny, J
    Pohlreich, P
    Zikan, M
    Cinek, P
    Janatova, M
    Petruzelka, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 844S - 844S
12345